ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Iconix Biosciences, Inc | JoVE Visualize

Home
Research Domains
Information And Computing Sciences

Iconix Biosciences, Inc

Mark R Fielden¹, Donald N Halbert

¹Iconix Biosciences, Inc., Molecular and Investigative Toxicology, 325 E Middlefield Road, Mountain View, CA 94043, USA. mfielden@iconixbiosciences.com

Pharmacogenomics|March 30, 2007

View abstract on PubMed

Summary

Iconix Biosciences utilizes proprietary genomic technologies for faster, cost-effective drug candidate profiling. This toxicogenomics approach enhances toxicity testing accuracy and speed, aiming to reduce late-stage failures in drug development.

Area of Science:

Genomics
Toxicology
Drug Discovery

Background:

Traditional toxicity testing is slow and costly.
High failure rates in late-stage preclinical drug development.
Need for more accurate and efficient methods.

Purpose of the Study:

To introduce novel genomic technologies for drug candidate profiling.
To enhance the accuracy, sensitivity, and speed of toxicity testing.
To establish toxicogenomics as a standard practice in pharmaceutical R&D.

Main Methods:

Application of proprietary genomic technologies.
Profiling of candidate drug compounds.
Focus on early discovery and preclinical development stages.

Main Results:

Improved understanding of candidate drugs.
Faster and more cost-effective drug development.
Increased accuracy and sensitivity in toxicity testing.

Conclusions:

Toxicogenomics adoption is growing within the toxicology community.
This paradigm shift promises significant impact on late-stage failure rates.
Strategic growth and research are driving toxicogenomics towards industry standardization.

Software Engineering

Software Testing, Verification And Validation

Iconix Biosciences, Inc